The COVID-19 pandemic exposed the risks and fragility inherent in global pharmaceutical and biotechnology supply chains. This isn’t really news though. For some time, these supply chains have lagged other industries in speed, flexibility, agility, redundancy, and diversification. With risk considerations at the forefront resulting from shortages during the pandemic, the US government is [...]
About Rashi GuptaThis author has not yet filled in any details.
So far Rashi Gupta has created 1 blog entries.